Stay updated on LANRA + Gilteritinib in FLT3+ R/R AML Clinical Trial

Sign up to get notified when there's something new on the LANRA + Gilteritinib in FLT3+ R/R AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the LANRA + Gilteritinib in FLT3+ R/R AML Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    - Added a government operations notice and operating details, plus a new v3.2.0 revision. - Removed the previous v3.1.0 revision.
    Difference
    11%
    Check dated 2025-10-05T17:25:33.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no substantive content changes detected.
    Difference
    0.3%
    Check dated 2025-09-28T10:38:09.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.
    Difference
    0.6%
    Check dated 2025-09-14T00:21:59.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1.
    Difference
    0.7%
    Check dated 2025-09-06T21:18:34.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location details, while removing specific state, country, and city information. This indicates a shift towards a more generalized presentation of location data.
    Difference
    28%
    Check dated 2025-08-30T15:45:09.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.3%
    Check dated 2025-08-16T12:46:06.000Z thumbnail image

Stay in the know with updates to LANRA + Gilteritinib in FLT3+ R/R AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the LANRA + Gilteritinib in FLT3+ R/R AML Clinical Trial page.